Vaxart, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (11)

Latest Posts

About This Stock More About This Stock
Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants
Article By: Benzinga
Tuesday, May 4, 2021 7:59 AM EST
Vaxart Inc has announced new data from the Phase 1 trial evaluating its oral COVID-19 vaccine candidate, dubbed as VXA-CoV2-1.
In this article: VXRT Also: PFE, MRNA, BNTX
Read
Vaxart Slides After Reporting Delay Of Trial For Potential COVID-19 Oral Vaccine
Article By: The Fly
Monday, May 3, 2021 3:08 PM EST
Shares of Vaxart are under pressure on Monday after the company reported worse-than-expected first quarter losses and said that its Phase II trial of VXA-CoV2-1 is now expected to start mid-year 2021 instead of in the second quarter.
In this article: VXRT
Read
2 Biopharma Stocks Looking To Make A Difference Against COVID-19: Technical Levels To Watch
Article By: Benzinga
Monday, May 3, 2021 1:17 PM EST
Shares of Ocugen Inc. and Vaxart Inc. are moving Monday, May 3. Ocugen shares gapped higher after the company's studies showed that COVAXIN is potentially effective against three key variants of SARS-CoV-2.
In this article: VXRT, OCGN
Read
Market Briefing For Monday, Aug. 31
Article By: Gene Inger
Sunday, August 30, 2020 8:03 PM EST
This continues our case for continued erratic behavior (rotating on news too); but not catastrophe, even if you get a shakeout of juggernauts along the way.
In this article: SPX, ABT, BMY, PFE, INO, SRNE, MRNA, HTBX, VXRT
Read
US Stock Market Weekly Review Aug. 23-28
Article By: Stavros Georgiadis
Saturday, August 29, 2020 11:49 PM EST
The valuations of stocks at these new record highs are of major concern.
In this article: CPST, ALT, VXRT, VVPR
Read

Latest Tweets for $VXRT

No tweets yet!

PARTNER HEADLINES

$VXRT

Vaxart: Slightly Cautious, Mostly Bullish
Corey Gaber 3/29/2020 3:07:08 AM

I'm bullish on $VXRT

1 to 1 of 1 comments